Contraception
Volume 77, Issue 4 , Pages 308-314 , April 2008

Cervical preparation for surgical abortion from 20 to 24 weeks' gestation

References 

  1. Strauss LT, Gamble SB, Parker WY, Cook DA, Zane SB, Hamdan S. Abortion surveillance — United States, 2003. MMWR Surveill Summ. 2006;55:1–32[Evidence Grade: II-3]
  2. Finer LB, Henshaw SK. Abortion incidence and services in the united states in 2000. Perspect Sex Reprod Health. 2003;35:6–15[Evidence Grade: II-3]
  3. Tietze C, Pakter J, Berger GS. Mortality with legal abortion in New York City, 1970–1972. A preliminary report. Jama. 1973;225:507–509[Evidence Grade: III]
  4. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by dilatation and evacuation: An analysis of 11,747 cases. Obstet Gynecol. 1983;62:185–190[Evidence Grade: II-3]
  5. Patel A, Talmont E, Morfesis J, Pelta M, Gatter M, Momtaz MR, et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 2006;73:420–430[Evidence Grade: II-3]
  6. Herczeg J, Sas M, Szabo J, Vajda G. Pre-evacuation dilatation of the pregnant uterine cervix by laminaria japonica. Acta Med Hung. 1986;43:145–154[Evidence Grade: II]
  7. Eaton CJ, Cohn F, Bollinger CC. Laminaria tent as a cervical dilator prior to aspiration-type therapeutic abortion. Obstet Gynecol. 1972;39:535–537[Evidence Grade: II-3]
  8. Krammer J, O'Brien WF. Mechanical methods of cervical ripening. Clin Obstet Gynecol. 1995;38:280–286[Evidence Grade: III]
  9. Newton BW. Laminaria tent: relic of the past or modern medical device?. Am J Obstet Gynecol. 1972;113:442–448[Evidence Grade: II-3]
  10. Gilson GJ, Russell DJ, Izquierdo LA, Qualls CR, Curet LB. A prospective randomized evaluation of a hygroscopic cervical dilator, Dilapan, in the preinduction ripening of patients undergoing induction of labor. Am J Obstet Gynecol. 1996;175:145–149[Evidence Grade: II-1]
  11. Hern WM. Laminaria versus Dilapan osmotic cervical dilators for outpatient dilation and evacuation abortion: Randomized cohort comparison of 1001 patients. Am J Obstet Gynecol. 1994;171:1324–1328[Evidence Grade: II-3]
  12. Lichtenberg ES. Complications of osmotic dilators. Obstet Gynecol Surv. 2004;59:528–536[Evidence Grade: III]
  13. Darney PD. Preparation of the cervix: hydrophilic and prostaglandin dilators. Clin Obstet Gynaecol. 1986;13:43–51[Evidence Grade: III]
  14. Karim SM, Sharma SD. Therapeutic abortion and induction of labour by the intravaginal administration of prostaglandins e 2 and f 2. J Obstet Gynaecol Br Commonw. 1971;78:294–300[Evidence Grade: II]
  15. Wiquist N, Bydgeman M. Therapeutic abortion by local administration of prostaglandins. Lancet. 1970;2:716–717[Evidence Grade: II]
  16. Mitchell MD, Flint AP, Turnbull AC. Stimulation of uterine activity by administration of prostaglandin f-2alpha during parturition in sheep. J Reprod Fertil. 1976;48:189–190[Evidence Grade: II]
  17. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med. 2001;344:38–47[Evidence Grade: III]
  18. Baulieu EE. Ru 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996. Ann N Y Acad Sci. 1997;828:47–58[Evidence Grade: II]
  19. Cadepond F, Ulmann A, Baulieu EE. Ru486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med. 1997;48:129–156[Evidence Grade: II]
  20. Harlap S, Shiono PH, Ramcharan S, Berendes H, Pellegrin F. A prospective study of spontaneous fetal losses after induced abortions. N Engl J Med. 1979;301:677–681[Evidence Grade: II]
  21. Schulz KF, Grimes DA, Cates W. Measures to prevent cervical injury during suction curettage abortion. Lancet. 1983;1:1182–1185[Evidence Grade: II-2]
  22. Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol. 2002;187:393–397[Evidence Grade: II-2]
  23. Grimes DA, Schulz KF. Morbidity and mortality from second-trimester abortions. J Reprod Med. 1985;30:505–514[Evidence Grade: II-3]
  24. Wright CS, Campbell S, Beazley J. Second-trimester abortion after vaginal termination of pregnancy. Lancet. 1972;1:1278–1279[Evidence Grade: III]
  25. Hern WM. Serial multiple laminaria and adjunctive urea in late outpatient dilatation and evacuation abortion. Obstet Gynecol. 1984;63:543–549[Evidence Grade: II-3]
  26. Jacot FR, Poulin C, Bilodeau AP, Morin M, Moreau S, Gendron F, et al. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J Obstet Gynecol. 1993;168:633–637[Evidence Grade: II-3]
  27. Grimes DA, Schulz KF, Cates WJ. Prevention of uterine perforation during curettage abortion. JAMA. 1984;251:2108–2111[Evidence Grade: II-2]
  28. Cates W, Grimes DA. Deaths from second trimester abortion by dilatation and evacuation: causes, prevention, facilities. Obstet Gynecol. 1981;58:401–408[Evidence Grade: II-3]
  29. Cates W, Schulz KF, Grimes DA. The risks associated with teenage abortion. N Engl J Med. 1983;309:621–624[Evidence Grade: II-2]
  30. Atienza MF, Burkman RT, King TM. Midtrimester abortion induced by hyperosmolar urea and prostaglandin f2 alpha in patients with previous cesarean section: clinical course and potential for uterine rupture. Am J Obstet Gynecol. 1980;138:55–59[Evidence Grade: II-3]
  31. Gold J. The safety of laminaria and rigid dilators for cervical dilation prior to suction curettage for first trimester abortion: a comparative analysis. In:  Naftolin F,  Stubblefield P editor. Dilation of the uterine cervix. New York: Raven Press; 1980;p. 363–369[Evidence Grade: III]
  32. Goldberg AB, Drey EA, Whitaker AK, Kang MS, Meckstroth KR, Darney PD. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet Gynecol. 2005;106:234–241[Evidence Grade: I]
  33. Borgatta L, Barad D. Prolonged retention of laminaria fragments: an unusual complication of laminaria usage. Obstet Gynecol. 1991;78:988–990[Evidence Grade: III]
  34. Chanda M, Mackenzie P, Day JH. Hypersensitivity reactions following laminaria placement. Contraception. 2000;62:105–106[Evidence Grade: III]
  35. Acharya PS, Gluckman SJ. Bacteremia following placement of intracervical laminaria tents. Clin Infect Dis. 1999;29:695–697[Evidence Grade: III]
  36. Sutkin G, Capelle SD, Schlievert PM, Creinin MD. Toxic shock syndrome after laminaria insertion. Obstet Gynecol. 2001;98:959–961[Evidence Grade: III]
  37. Grimes DA, Ray IG, Middleton CJ. Lamicel versus laminaria for cervical dilation before early second-trimester abortion: a randomized clinical trial. Obstet Gynecol. 1987;69:887–890[Evidence Grade: I]
  38. Hogue CJ. Impact of abortion on subsequent fecundity. Clin Obstet Gynaecol. 1986;13:95–103[Evidence Grade: II]
  39. Lauersen NH, Den T, Iliescu C, Wilson KH, Graves ZR. Cervical priming prior to dilatation and evacuation: a comparison of methods. Am J Obstet Gynecol. 1982;144:890–894[Evidence Grade: II-1]
  40. Allen RH, Goldberg AB. Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). SFP guideline 20071. Contraception. 2007;76:139–156[Evidence Grade: III]
  41. Fox , Hayes . Cervical dilation before second trimester surgical abortion (15-19 week's gestation). SFP guideline 20072. Contraception. 2007;76:486–495[Evidence Grade: II]
  42. Kalish RB, Chasen ST, Rosenzweig LB, Rashbaum WK, Chervenak FA. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol. 2002;187:882–885[Evidence Grade: II]
  43. Hern WM. Cervical treatment with Dilapan prior to second trimester dilation and evacuation abortion: a pilot study of 64 patients. Am J Gynecol Health. 1993;7:23–26[Evidence Grade: II-2]
  44. Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG. A clinician's guide to medical and surgical abortion. 1st ed. Philadelphia, PA: Churchill Livingstone; 1999;[Evidence Grade: III]
  45. Buehler JW, Schulz KF, Grimes DA, Hogue CJ. The risk of serious complications from induced abortion: do personal characteristics make a difference?. Am J Obstet Gynecol. 1985;153:14–20[Evidence Grade: II-2]
  46. Herczeg J. Pretreatment of the cervix prior to surgical evacuation of the uterus in the late first and early second trimester of pregnancy. Baillieres Clin Obstet Gynaecol. 1990;4:307–325[Evidence Grade: II-2]
  47. Stubblefield P. Laminaria and other adjunctive methods. In:  Berger G,  Brenner W,  Keith L editor. Second trimester abortion: perspectives after a decade of experience. Boston, MA: John Wright PSG; 1981;p. 135–161[Evidence Grade: III]
  48. Munsick RA, Fineberg NS. Cervical dilation from multiple laminaria tents used for abortion. Obstet Gynecol. 1996;87:726–729[Evidence Grade: II-2]
  49. Poon LC, Parsons J. Audit of the effectiveness of cervical preparation with Dilapan prior to late second-trimester (20–24 weeks) surgical termination of pregnancy. BJOG. 2007;114:485–488[Evidence Grade: II-3]
  50. Stubblefield PG, Altman AM, Goldstein SP. Randomized trial of one versus two days of laminaria treatment prior to late midtrimester abortion by uterine evacuation: a pilot study. Am J Obstet Gynecol. 1982;143:481–482[Evidence Grade: I]
  51. Schneider D, Halperin R, Langer R, Caspi E, Bukovsky I. Abortion at 18–22 weeks by laminaria dilation and evacuation. Obstet Gynecol. 1996;88:412–414[Evidence Grade: II-3]
  52. Edelman AB, Buckmaster JG, Goetsch MF, Nichols MD, Jensen JT. Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. Am J Obstet Gynecol. 2006;194:425–430[Evidence Grade: I]
  53. Berghahn L, Christensen D, Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstet Gynecol. 2001;98:976–977[Evidence Grade: III]
  54. Bhattacharjee N, Ganguly RP, Saha SP. Misoprostol for termination of mid-trimester post-caesarean pregnancy. Aust N Z J Obstet Gynaecol. 2007;47:23–25[Evidence Grade: II-2]
  55. Daskalakis GJ, Mesogitis SA, Papantoniou NE, Moulopoulos GG, Papapanagiotou AA, Antsaklis AJ. Misoprostol for second trimester pregnancy termination in women with prior caesarean section. BJOG. 2005;112:97–99[Evidence Grade: II-3]
  56. Dickinson JE. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol. 2005;105:352–356[Evidence Grade: II-3]
  57. Rouzi AA. Second-trimester pregnancy termination with misoprostol in women with previous cesarean sections. Int J Gynaecol Obstet. 2003;80:317–318[Evidence Grade: II]
  58. Chen M, Shih JC, Chiu WT, Hsieh FJ. Separation of cesarean scar during second-trimester intravaginal misoprostol abortion. Obstet Gynecol. 1999;94:840;[Evidence Grade: III]
  59. Chapman SJ, Crispens M, Owen J, Savage K. Complications of midtrimester pregnancy termination: the effect of prior cesarean delivery. Am J Obstet Gynecol. 1996;175:889–892[Evidence Grade: III]
  60. Mazouni C, Provensal M, Porcu G, Guidicelli B, Heckenroth H, Gamerre M, et al. Termination of pregnancy in patients with previous cesarean section. Contraception. 2006;73:244–248[Evidence Grade: II]
  61. Partial-birth abortion ban act of 2003. 18 U.S.C. §1531 (2003).
  62. Gonzales v. Carhart 127 S.Ct. 1610 (2007).

PII: S0010-7824(08)00031-0

doi: 10.1016/j.contraception.2008.01.004

Contraception
Volume 77, Issue 4 , Pages 308-314 , April 2008

Article Tools